The precise etiology of inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (CU) is poorly understood and remains a field of intense investigation. IBD are characterised by imbalanced activation of the intestinal immune system leading to the destruction of the mucosa. T lymphocytes are known to play a fundamental role in regulating the immune response caused by distinct antigens. Imbalanced activation of Th1 and Th2 lymphocytes has been shown to be crucial for the initiation and maintenance of destructive inflammation of the intestine. [1] [2] [3] The importance of activated Th1 lymphocytes and the consecutive production of proinflammatory cytokines like IL-2 and IFN-␥ has been established in mouse models for IBD. 4 Th2 lymphocytes downregulate the activation of Th1 lymphocytes by secreting cytokines like IL-4, IL-10 or IL-13. 5 There is increasing evidence from epidemiological and genome-wide linkage studies that genetic factors play an important role in the predisposition to IBD. Several chromosomal regions have been identified to be linked to IBD, however the respective genes are still unknown. [6] [7] [8] Many functionally relevant polymorphisms in cytokine genes have been described recently. Polymorphisms in genes involved in the regulation of Th1 and Th2 lymphocytes are excellent genetic markers for association studies to define predisposing alleles. IL-4 is secreted by Th2 lymphocytes and it interacts with the IL-4 receptor The IL-4 gene is located in the chromosomal region 5q31-33 and the IL-4RA gene maps to 16p12.1. Linkage has been shown for the two regions to CD. 6, 7 Consequently, these genes are good candidates both by position and by functional reasoning for genetic predisposition.
One of the single nucleotide polymorphism (SNP) with functional relevance for transcription in the IL-4 gene has been described in the promoter (C/T at position −590).
9-
11 Several SNPs are located within the IL-4R␣ gene. Two SNPs leading to an amino acid exchange (Ile50Val and Glu576Arg) have been found to be associated with atopy. 12, 13 In order to evaluate the role of the aforementioned polymorphisms in the genetic predisposition for IBD, we genotyped of 215 patients with CD, 156 UC and 446 healthy controls of Caucasian origin.
Blood samples were collected at the universities of Bochum, Munich and Jena. Diagnoses were confirmed by clinical, endoscopical and histological parameters. Control samples have been described before.
14 DNA was isolated from EDTA-anticoagulated blood after standard protocols. 15 The polymorphism of the IL-4 gene was genotyped by RFLP analyses as described by Kawashima et al. 11 Genotyping of the IL-4R␣ SNPs was performed by SSCP analyses
Comparison of the allele, genotype and carrier frequencies of the SNPs in the IL-4R␣ gene revealed no significant differences between patients and controls (see Table 1 ). This result is in accordance with the report of Olavsen et al. 16 For the IL-4 gene the percentage of −590T allele carriers was reduced among CD patients compared P] ␣ dCTP (10 mCi/ml) was run in a Thermocycler (Trio-Block, Biometra). After two initial cycles at 6°C and 3°C above the annealing temperature, 25 cycles of 95°C, annealing temperature (Q576R. 56°C; I50V: 53°C) and 72°C were run for 0.5, 1 and 1 min, respectively. For SSCP analyses 3 l of PCR product was mixed with 95% formamide, 10 mm NaOH, 20 mm EDTA, 0.02% xylene cyanol and 0.02% bromophenol blue. The samples were heated for 4 min at 95°C and cooled on ice immediately. Three l of each mix was run on 50 cm vertical polyacrylamide gels containing 10% glycerine at constant 50W in a 4°C cold room for 4 h. 20 Gels were dried and subjected to autoradiography overnight.
to controls (P Ͻ 0.03; see Table 2 ). Thus, our data suggest that CD is associated with decreased production of IL-4. Hence, these results are in contrast to the published association studies 17 which described an increased carrier frequency of the T allele of a SNP at position −34 of the IL-4 gene. The latter allele is tightly linked to −590T
18 as also confirmed in our cohort (Klein, unpublished data). Aithal et al 17 had suggested increased IL-4 signalling in CD.
Such conflicting data may be explained by falsepositive association in one study by chance or due to differences in the population stratification in the patient and control cohorts. Many significant results have been described in association studies which have not been reproduced. 11, 19 Yet, comparing the findings of Aithal et al 17 and the present report, this is the first instance that 
